TSHR-based therapeutic approaches, including small-molecule drugs, nanomaterials, and advanced immunotherapies, represent new avenues for treating thyroid cancer, particularly in patients who have developed resistance to traditional treatments, such as radioiodine therapy (Fig. 2). The gene discussed is TSHR; the disease is thyroid cancer.